Perry Gordon

Statistics

Publications

Citations

827

H-Index

Active since

2003

Affiliations

Genomics Institute of the Novartis Research Foundation(Current)

University of California San Diego

Scripps Research Institute

Perry Gordon is an author at Genomics Institute of the Novartis Research Foundation specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2003–2020

Publications

Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery

Stephan Meister, David Plouffe, Kelli Kuhen et al. · Science · 2011 · 347 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Modulation of Nonspecific Binding in Ultrafiltration Protein Binding Studies

Kyoung‐Jin Lee, Rachel Mower, Tom Hollenbeck et al. · Pharmaceutical Research · 2003 · 129 citations

Life Sciences, Biochemistry, Biophysics +7

Discovery of (R,E)-N-(7-Chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung Cancers

G. Lelais, Robert Epple, Thomas H. Marsilje et al. · Journal of Medicinal Chemistry · 2016 · 95 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases

Xiaohui He, Sara Da Ros, John T. Nelson et al. · ACS Medicinal Chemistry Letters · 2017 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Identification of novel potent bicyclic peptide deformylase inhibitors

Valentina Molteni, Xiaohui He, Juliet Nabakka et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

1–5 of 12